🚨 JUST IN: $TBPH
Theravance completes $17/share cash-plus-CVR merger with Zymeworks; delists from Nasdaq
#SEC #stocks #investing #TBPH #Mergers
đź”— secwatch.observer
@secwatch.bsky.social
@secwatch.bsky.social🚨 JUST IN: $TBPH
Theravance completes $17/share cash-plus-CVR merger with Zymeworks; delists from Nasdaq
#SEC #stocks #investing #TBPH #Mergers
đź”— secwatch.observer
@secwatch.bsky.social🚨 JUST IN: $TBPH
Theravance discloses three shareholder lawsuits over Zymeworks merger, supplements proxy
#SEC #stocks #investing #TBPH #Litigation
đź”— secwatch.observer
